MARKER THERAPEUTICS, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
MARKER THERAPEUTICS, INC. (MRKR) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $500.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- MARKER THERAPEUTICS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- MARKER THERAPEUTICS, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |